Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Filament Health Corp (OP:FLHLF)

0.0160 -0.0026 (-13.98%)
Streaming Delayed Price Updated: 3:55 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Filament Health Corp

< Previous 1 2 3 Next >
Optimi Health Signs Two New Supply Agreements In Less Than a Week
Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. 
Via Benzinga
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say
Patents are the golden eggs of the booming psychedelic space. 
Via Benzinga
Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth
Just two weeks ago, Filament Health (OTCQB: FLHLF) was issued a patent by the U. S. Patent and Trademark Office to extract and standardize natural psilocybin. 
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market
Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. 
Via Benzinga
Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know
Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the... 
Via Benzinga
Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin
Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and... 
Via Benzinga
Filament Health Corp. (FLHLF) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. 
Via Benzinga
Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants
Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants. 
Via Benzinga
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... 
Via Benzinga
How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions
Image by Mathew Schwartz from Unsplash The following post was written and/or pu... 
Via Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
Detroit Decriminalizes Psychedelics 
Via Benzinga
Exposures Product Safety
The Power Play by The Market Herald Releases New Interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven Brands Inc., and Xali Gold Corp.
VANCOUVER, BC / ACCESSWIRE / November 3, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven... 
From The Market Herald
Via AccessWire
Topics Cannabis
Exposures Cannabis Product Safety
Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial
Psychedelic drug discovery company Filament Health Corp. (OTCQB: 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.